Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes suffer

For the past six months, 14-year-old Freya Goldston has attended more school, swimming training and increased her time with friends — but that quality of life is now at risk.

Fiasp, the ultra-fast insulin she relies on to treat her type 1 diabetes will be taken off the Pharmaceutical Benefits Scheme (PBS) next month, sending the price soaring.

The Sunshine Coast teenager started taking Fiasp after it was approved for people under 18, and said the medication has had an "incredible impact" on her life.

"It's really helped me just feel normal," Freya said.

Read More: https://www.abc.net.au/news/2023-03-02/ultra-fast-insulin-fiasp-diabetes-drug-removed-from-pbs/102043628